<DOC>
	<DOCNO>NCT00318617</DOCNO>
	<brief_summary>The purpose study determine effect 4-week treatment period GW501516X heart obtain use energy . The energy heart measure Magnetic Resonance Imaging ( MRI ) . This study also measure number potential marker drug activity , include level certain lipid ( fat ) proteins blood . The data study may help researcher well understand action drug body drug may useful treat patient heart disease .</brief_summary>
	<brief_title>Effect Of GW501516X On How The Heart Obtains And Uses Energy</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Inclusion criterion : Nonsmoking . Body Mass Index great 27 less 32 weigh 120 kg ( 264 lb ) less waist circumference great 95 cm ( 37.5 inch ) . Exclusion criterion : History muscle disease , coagulation disorder , heart disease abnormal heart rhythm ( family history early coronary artery disease ) . Documented diabetes , hypoglycemia , thyroid disfunction adrenal disorder .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>peroxisome proliferator activate receptor ,</keyword>
	<keyword>PPARs ,</keyword>
	<keyword>Heart Failure ,</keyword>
	<keyword>cardiac energetics ,</keyword>
	<keyword>MRI ,</keyword>
	<keyword>GW501516X</keyword>
	<keyword>fatty acid metabolism ,</keyword>
</DOC>